Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Neuromuscular Disorders : NMD|April 19, 2017
Cytoplasmic body pathology in severe ACTA1-related myopathy in the absence of typical nemaline rodsSandra Donkervoort, Sophelia H S Chan, Leslie H Hayes, et al.Journal of Neuromuscular Diseases|November 19, 2023
Findings from the Longitudinal CINRG Becker Natural History StudyPaula R Clemens, Heather Gordish-Dressman, Gabriela Niizawa, et al.British Journal of Haematology|September 11, 2012
Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemiaMathula Thangarajh, Genyan Yang, Dana Fuchs, et al.Neurology|March 16, 2018
A multinational study on motor function in early-onset FSHDJean K Mah, Jia Feng, Marni B Jacobs, et al.Muscle & Nerve|June 22, 2020
The CINRG Becker Natural History Study: Baseline characteristicsPaula R Clemens, Gabriela Niizawa, Jia Feng, et al.Journal of Personalized Medicine|November 24, 2020
Multi-Omics Identifies Circulating miRNA and Protein Biomarkers for Facioscapulohumeral DystrophyChristopher R Heier, Aiping Zhang, Nhu Y Nguyen, et al.Contemporary Clinical Trials Communications|August 11, 2018
Recruitment & retention program for the NeuroNEXT SMA Biomarker Study: Super Babies for SMA!Amy Bartlett, Stephen J Kolb, Allison Kingsley, et al.Annals of Neurology|November 18, 2017
Natural history of infantile-onset spinal muscular atrophyStephen J Kolb, Christopher S Coffey, Jon W Yankey, et al.Annals of Clinical and Translational Neurology|February 23, 2016
Baseline results of the NeuroNEXT spinal muscular atrophy infant biomarker studyStephen J Kolb, Christopher S Coffey, Jon W Yankey, et al.Contemporary Clinical Trials|April 29, 2017
Developing standardized corticosteroid treatment for Duchenne muscular dystrophyMichela Guglieri, Kate Bushby, Michael P McDermott, et al.Pageof 4